Rapid Screening for EGFR Inhibitor in Rhei Radix et Rhizoma by HTRF Assay Coupled with HPLC Peak Fractionation

Abstract

In this paper, an HPLC peak fractionation approach combined with homogeneous time-resolved fluorescence analysis is proposed for screening epidermal growth factor receptor inhibitors from Rhei Radix et Rhizoma. With this approach, the amount of sample used for a single HPLC run is sufficient for performing a multiple assay due to the miniaturization ability of the homogeneous time-resolved fluorescence technology. This allows for improving the stability and repeatability of the activity assay for each fraction. From a total of 26 fractions collected from the Rhei Radix et Rhizoma extract, 13 fractions exhibit inhibitory activity against the epidermal growth factor receptor. The structures of activity compounds were determined by HPLC-LTQ-Orbitrap MS, revealing the presence of gallic acid, rhein, and emodin with IC₅₀ values of 21.5, 5.29, and 10.2 µM, respectively. The ligand epidermal growth factor receptor interactions were explored by molecular docking simulations, and the inhibitory effects of the three compounds on A549 cell growth were tested in vitro by an MTT assay. This study demonstrates the suitability of the present screening method for drug discovery in natural products.

Key words

Peak fractionation - HTRF - EGFR - Rheum palmatum - Polygonaceae

Publication History

Received: 05 April 2020

Accepted after revision: 21 September 2020

Article published online:
11 November 2020

• References

• 1 Fu Y, Luo J, Qin J, Yang M. Screening techniques for the identification of bioactive compounds in natural products. J Pharm Biomed Anal 2019; 168: 189-200
• 2 Yin B, Fang D, Zhou X, Gao F. Natural products as important tyrosine kinase inhibitors. Eur J Med Chem 2019; 182: 111664
• 3 Guo J, Lin H, Wang J, Lin Y, Zhang T, Jiang Z. Recent advances in bio-affinity chromatography for screening bioactive compounds from natural products. J Pharm Biomed Anal 2019; 165: 182-197
• 4 Zhang Q, Lin L, Ye W. Techniques for extraction and isolation of natural products: a comprehensive review. Chin Med 2018; 13: 20-46
• 5 Zhang H, Luo L, Song H, Hao H, Zhou P, Qi L, Li P, Chen J. A high-resolution peak fractionation approach for streamlined screening of nuclear-factor-E2-related factor-2 activators in Salvia miltiorrhiza . J Chromatogr A 2014; 1326: 47-55
• 6 Liu J, Luo L, Zhang H, Jia B, Lu J, Li P, Chen J. Rapid screening for novel antioxidants in Glycyrrhiza inflata using high-resolution peak fractionation. J Funct Foods 2015; 6: 40-49
• 7 Lu J, Song H, Li P, Zhou P, Dong X, Chen J. Screening of direct thrombin inhibitors from Radix Salviae Miltiorrhizae by a peak fractionation approach. J Pharm Biomed Anal 2015; 109: 85-90
• 8 Tu Y, Jeffries C, Ruan H, Nelson C, Smithson D, Shelat AA, Brown KM, Li X, Hester JP, Smillie T, Khan IA, Walker L, Guy K, Yan B. Automated high-throughput system to fractionate plant natural products for drug discovery. J Nat Prod 2010; 73: 751-754
• 9 Degorce F. HTRF(^®): pioneering technology for high-throughput screening. Expert Opin Drug Discov 2006; 1: 753-764
• 10 Degorce F, Card A, Soh S, Trinquet E, Knapik GP, Xie B. HTRF: A technology tailored for drug discovery – a review of theoretical aspects and recent applications. Curr Chem Genomics 2009; 3: 22-32
• 11 Jia Y, Manuia M, Juarez J. HTRF kinase assay development and methods in inhibitor characterization. Methods Mol Biol 2016; 1360: 1-18
• 12 Hong L, Quinn CM, Jia Y. Evaluating the utility of the HTRF Transcreener ADP assay technology: a comparison with the standard HTRF assay technology. Anal Biochem 2009; 391: 31-38
• 13 Sharma SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007; 7: 169-181
• 14 Ciardiello F, Tortora G. Drug therapy: EGFR antagonists in cancer treatment. N Engl J Med 2008; 358: 1160-1174
• 15 Ciardello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 2009; 360: 1579
• 16 von Ahsen O, Bömer U. High-throughput screening for kinase inhibitors. Chembiochem 2005; 6: 481-490
• 17 Kadioglu O, Cao J, Saeed MEM, Greten HJ, Efferth T. Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals. Target Oncol 2015; 10: 337-353
• 18 Ma J, Qi L, Li H, Li P. A segmental monitoring strategy based on variable wavelength detection for quality control of three Polygonaceae herbs. J Pharm Biomed Anal 2012; 62: 155-161
• 19 Lee MS, Cha EY, Sul JY, Song IS, Kim JY. Chrysophanic acid blocks proliferation of colon cancer cells by inhibiting EGFR/mTOR pathway. Phytother Res 2011; 25: 833-837
• 20 El-Saied MA, Sobeh M, Abdo W, Badr OM, Youssif LT, Elsayed IH, Osman SM, Wink M. Rheum palmatum root extract inhibits hepatocellular carcinoma in rats treated with diethylnitrosamine. J Pharm Pharmacol 2018; 70: 821-829
• 21 Wang Q, Lu Z, Zhang L, Zhang Q, Wang M, Zhao H, Liu Y, Fu S, Huang Z, Xie Z, Yu H, Zhang Z, Gao X. Applying characteristic fragment filtering for rapid detection and identification of ingredients in rhubarb by HPLC coupled with linear ion trap-Orbitrap mass spectrometry. J Sep Sci 2017; 40: 2854-2862
• 22 Feng S, Li M, Zhao D, Li X, Zhang L, Wang Z, Gao N. Simultaneous determination of 10 anthraquinones in rhubarb based on HPLC-Q-HR/MS. Chine Herbal Medic 2017; 9: 388-395
• 23 Efferth T, Li PC, Konkimalla VSB, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007; 13: 353-361
• 24 Sreelakshmi V, Navya R, Annie A. Evaluation of the drug-like properties of kaempferol, chrysophanol and emodin and their Interactions with EGFR tyrosine kinase – an in silico approach. Nat Prod Comm 2017; 12: 915-920
• 25 Su Z, Tian W, Li J, Wang C, Pan Z, Li D, Hou H. Biological evaluation and molecular docking of rhein as a multi-targeted radiotherapy sensitization agent of nasopharyngeal carcinoma. J Mol Struct 2017; 1147: 462-468
• 26 Cheng H, Nair SK, Murray BW. Recent progress on third generation covalent EGFR inhibitors. Bioorg Med Chem Lett 2016; 26: 1861-1868
• 27 Nasab RR, Mansourian M, Hassanzadeh F, Shahlaei M. Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of in-silico and in-vitro cytotoxicity methods. Res Pharm Sci 2018; 13: 509-522
• 28 Wang D, Bao B. Gallic acid impedes non-small cell lung cancer progression via suppression of EGFR-dependent CARM1-PELP1 complex. Drug Des Devel Ther 2020; 14: 1583-1592
• 29 Yang L, Li J, Xu L, Lin S, Xiang Y, Dai X, Liang G, Huang X, Zhu J, Zhao C. Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway. Cancer Manag Res 2019; 11: 1167-1176
• 30 Li W, Ng YF, Zhang H, Guo ZD, Guo DJ, Kwan YW, Leung GP, Lee SM, Yu PH, Chan SW. Emodin elicits cytotoxicity in human lung adenocarcinoma A549 cells through inducing apoptosis. Inflammopharmacology 2014; 22: 127-134
• 31 Bruggisser R, Von Daeniken K, Jundt G, Schaffner W, Tullbergreinert H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med 2002; 68: 445-448